TMTP1-ICG Mapping in Colposcopy-directed Biopsy

Novel Tumor Targeted Fluorescent TMTP1-ICG Mapping in Colposcopy-directed Biopsy

Investigators aimed to determine the validity of the novel tumor targeted fluorescent TMTP1-ICG to increased accuracy of colposcopy-directed biopsy.

Inclusion Criteria:

• Suspicious of cervical disease required a colposcopy-directed biopsy.
• Subjects must sign an informed consent indicating awareness of the investigational nature of this study.

Exclusion Criteria:

• Breast-feeding or pregnant.
• Ongoing participation in another clinical trial with an investigational drug with 3 months.
• Own allergy towards ICG and/or alcohol.
• Diagnosis of bacterial vaginosis, fungal vaginitis, sexually transmitted diseases.
• Patients with cardiac dysfunction or hepatic insufficiency or renal insufficiency.